Safety and toxicity of fetal whole ganglionic eminence progenitor cell transplantation in Huntington's Disease patients

Tobias Piroth, Elisabeth Schültke, Michael Trippel, Jaroslaw Maciaczyk & Guido Nikkhah
Objective: The European multicentre trial MIG-HD aims on the replacement of lost striatal projection neurons using fetal progenitor cells. Available data from the German branch of the trial provides information on side effects and benefits. Risk assessment is based on pharmacological safety, involving[for full text, please go to the a.m. URL]